Thomas Byron Neff
Keine laufenden Positionen mehr
Profil
Thomas Byron Neff is the founder of FibroGen, Inc. which was founded in 1993.
He held the titles of Chairman & Chief Executive Officer until 2019.
Mr. Neff also held former positions as Director at Kolltan Pharmaceuticals, Inc. from 2009 to 2016, Director at FibroGen China Anemia Holdings Ltd., Director at FibroGen Europe Oy from 1997 to 2019, Senior Vice President at Lazard Frères & Co. LLC from 1988 to 1992, and Principal at Painewebber Group, Inc. from 1983 to 1988.
He was also a Trustee at Claremont McKenna College.
Mr. Neff received his undergraduate degree from Claremont McKenna College and his graduate degree from The University of Chicago.
Ehemalige bekannte Positionen von Thomas Byron Neff
| Unternehmen | Position | Ende |
|---|---|---|
| FIBROGEN, INC. | Chief Executive Officer | 27.08.2019 |
| Fibrogen China Anemia Holdings Ltd. | Director/Board Member | 27.08.2019 |
| Claremont McKenna College | Director/Board Member | 27.08.2019 |
Fibrogen Europe Oy
 Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Director/Board Member | 27.08.2019 |
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Director/Board Member | 01.01.2016 |
Ausbildung von Thomas Byron Neff
| Claremont McKenna College | Undergraduate Degree |
| The University of Chicago | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Lazard Frères & Co. LLC
 Lazard Frères & Co. LLC Investment ManagersFinance Lazard Freres & Co. LLC provides corporate advisory, capital market, and asset management services. The company was founded on April 13, 1992 and is headquartered in New York, NY. | Finance |
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
| Fibrogen China Anemia Holdings Ltd. | |
| Painewebber Group, Inc. | Finance |
Fibrogen Europe Oy
Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Health Technology |
